states until 2001, where he managed the development and deployment of the electronic medical record for that region. He has been very active in the e-health, mobile health, and personal health records arena and has served on national-level workgroups related to consumer information empowerment and e-health. He was a member of the Task Force on Information Capture in 2001 and is also leading the Personal Medication Records project in the SOS Rx initiative, sponsored by the National Consumers League. In 2003-2004 he was actively engaged with the Medical Records Institute relative to mobile computing and the TEPR (Towards the Electronic Patient Record) awards. He is also very active in Health Tech Net, a Washington area consortium of health technology participants. He completed his B.A. at Bowdoin College, his M.D. at Northwestern University, and his neurology residency at the Mayo Clinic.
Marc L. Berger, M.D., is vice president for Outcomes Research and Management in the U.S. Human Health Division at Merck & Co., Inc While at Merck, Dr. Berger has held various positions of responsibility for Phase II to Phase IV clinical trials, outcomes research studies, and disease management programs. His current research interests include health-related productivity, cost-effectiveness analysis, and the value of pharmaceutical innovation. He was recently invited to serve on the CMS Medicare Coverage Advisory Committee. He also serves on advisory boards for the Health Industry Forum and the Program on the Economic Evaluation of Medical Technology (PEEMT) at the Harvard Center for Risk Analysis, as well as for the journal Value in Health. He holds appointments as adjunct senior fellow at the Leonard David Institute of Health Economics at the University of Pennsylvania and adjunct professor in the Department of Health Policy and Administration at the University of North Carolina at Chapel Hill School of Public Health. Prior to joining Merck, he was on the faculty of the University of Cincinnati School of Medicine. Dr. Berger obtained his M.D. from Johns Hopkins University School of Medicine. He completed an internal medicine residency at New York University-Bellevue Hospital and a Liver Research Fellowship at the University of Texas Southwestern Medical School.
Robert M. Califf, M.D., is vice chancellor for clinical research, director of the Duke Clinical Research Institute (DCRI), and professor of medicine in the division of cardiology at Duke University Medical Center. He is board certified in internal medicine and cardiology and is a fellow of the American College of Cardiology. Author or coauthor of more than 600 peer-reviewed journal articles, as well as major textbooks on cardiovascular disease, Dr. Califf has also served on the Cardiorenal Advisory Panel of the U.S. Food and Drug Administration (FDA) and the Pharmaceutical Roundtable